DEFINITIVE SOLUTION STRUCTURES FOR THE 6-FORMYLATED VERSIONS OF 1-(BETA-D-RIBOFURANOSYL)-, 1-(2'-DEOXY-BETA-D-RIBOFURANOSYL)-, AND 1-BETA-D-ARABINOFURANOSYLURACIL, AND OF THYMIDINE
Mp. Groziak et al., DEFINITIVE SOLUTION STRUCTURES FOR THE 6-FORMYLATED VERSIONS OF 1-(BETA-D-RIBOFURANOSYL)-, 1-(2'-DEOXY-BETA-D-RIBOFURANOSYL)-, AND 1-BETA-D-ARABINOFURANOSYLURACIL, AND OF THYMIDINE, Nucleosides & nucleotides, 15(5), 1996, pp. 1041-1057
ROESY and NOESY NMR spectroscopic analyses of the ribofuranosyl (la),
2'-deoxyribofuranosyl (Ib), and arabinofuranosyl (Ic) derivatives of 6
-formyluracil in (CD3)(2)SO and D2O solutions have established that ea
ch exclusive 7,O5'-cyclic hemiacetal diastereomer of la,b and the majo
r 7,O2'-cyclic hemiacetal diastereomer of Ic possess the 7R configurat
ion. In addition, (7R)-1c has been shown to be thermodynamically more
stable than (7S)-1c, contrary to our previous indication. A new, highe
r yielding synthetic route to in has been developed, Ib has been obtai
ned for the first time in crystalline form, the route to Ic has been m
odified to better accommodate large scale preparations, and a new, fou
rth member of this class, 6-formylthymidine (Id), has been synthesized
and its solution structures in (CD3)(2)SO, D2O, and CD3OD have been d
etermined. Antitumor and antiviral evaluations of la-e have revealed n
o significant levels of activity.